Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/BLISSGVS stock hub

NSE/BLISSGVS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NSE/BLISSGVSis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
28.5B
National Stock Exchange of India
Market data

Live price

Current market quote for this ticker.

Current price
NSE/BLISSGVS
In the news

Latest news · NSE/BLISSGVS

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 24.9P50 32.4P75 45.7
Trailing P/E26.1
P25 24.8P50 35.9P75 56.9
ROEn/a
P25 6.3P50 13.6P75 18.1
ROIC7.2
P25 4.1P50 10.3P75 17.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NSE/BLISSGVS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
192
Groups with data
10
Currency
INR
Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
India
Country code
IN
Employees
966
Employees Change
135%
Employees Change Percent
16.25
Enterprise value
INR 27.4B
Exchange
National Stock Exchange of India
Financial currency
INR
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
INE416D01022
Last refreshed
2026-05-10
Market cap
INR 28.5B
Price
INR 270
Price currency
INR
Rev Per Employee
8,986,598.34x
Sector
Healthcare
Sic
2834
Symbol
nse/BLISSGVS
Website
https://www.blissgvs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
3.83%
EV Earnings
25.09x
EV/EBIT
25.38x
EV/EBITDA
19.81x
EV/Sales
3.15x
P/B ratio
2.44x
P/E ratio
26.12x
P/S ratio
3.28x
PE Ratio10 Y
36.34x
PE Ratio3 Y
15.85x
PE Ratio5 Y
53.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
EBIT Margin
12.42%
EBITDA Margin
15.41%
Gross margin
50.71%
Gross Profit
INR 4.4B
Gross Profit Growth
15.38%
Gross Profit Growth Q
21.17%
Gross Profit Growth3 Y
8.74%
Gross Profit Growth5 Y
13.32%
Net Income
INR 1.1B
Net Income Growth
83%
Net Income Growth Q
-2.25%
Net Income Growth Years
3%
Net Income Growth3 Y
7.77%
Net Income Growth5 Y
8.97%
Pretax Margin
19.36%
Profit Margin
12.57%
Profit Per Employee
INR 1.1M
Profitable Years
21
Roa5y
5.59
Roe5y
7.59
ROIC
7.19
Roic5y
7.31

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

19
MetricValue
Cagr10y
10.15%
Cagr15y
18.06%
Cagr1y
135.43%
Cagr3y
53.53%
Cagr5y
20.05%
Div CAGR10
7.18%
Div CAGR3
25.99%
Div CAGR5
14.87%
EPS Growth
81.2
EPS Growth Q
-5.73
EPS Growth Years
3
EPS Growth3 Y
7.48
EPS Growth5 Y
8.5
Revenue Growth
7.19x
Revenue Growth Q
3.72x
Revenue Growth Quarters
3x
Revenue Growth Years
4x
Revenue Growth3 Y
5.76x
Revenue Growth5 Y
8.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

14
MetricValue
Cash
INR 2B
Debt
INR 524.9M
Debt EBITDA
INR 0.38
Debt Equity
INR 0.04
Equity
INR 11.7B
Interest Coverage
9.54
Net Cash
INR 1.5B
Net Cash By Market Cap
INR 5.2
Net Cash Growth
17.88%
Net Debt EBITDA
INR -1.11
Net Debt Equity
INR -0.13
Tangible Book Value
INR 11.2B
Tangible Book Value Per Share
INR 106
WACC
9.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
-1.06%
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
INR 1
Dividend Years
21
Dividend Yield
0.37%
Ex Div Date
2026-02-18
Last Dividend
INR 0.5
Payout Frequency
Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
10Y total return
162.84%
1Y total return
135.29%
200-day SMA
182.7
3Y total return
262.01%
50-day SMA
236.5
50-day SMA vs 200-day SMA
50over200
5Y total return
149.34%
All Time High
281
All Time High Change
-3.91%
All Time High Date
2026-04-28
All Time Low
18.8
All Time Low Change
1,336.17%
All Time Low Date
2011-10-03
ATR
11.28
Beta
0.95
Ch YTD
65.25
High
275.5
High52
281
High52 Date
2026-04-28
High52ch
-3.91%
Low
269.1
Low52
109
Low52 Date
2025-05-09
Low52ch
147.64%
Ma50ch
14.17%
Price vs 200-day SMA
47.78%
RSI
59.85
RSI Monthly
75.6
RSI Weekly
73.74
Sharpe ratio
1.67x
Sortino ratio
3.14
Total Return
-0.68%
Tr YTD
65.61
Tr15y
1,105.93%
Tr1m
13.91%
Tr1w
-1.5%
Tr3m
47.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
INR 1.1B
Operating Income Growth
2
Operating Income Growth Q
18.89
Operating Income Growth3 Y
-1.67
Operating Income Growth5 Y
3.75
Operating margin
12.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
42,204,022%
Shares Insiders
43.96%
Shares Institutions
10.9%
Shares Qo Q
1.34%
Shares Yo Y
1.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

49
MetricValue
Average Volume
1,415,404.85x
Bv Per Share
107.2
Ch10y
149.4
Ch15y
960.9
Ch1m
13.91
Ch1w
-1.5
Ch1y
134
Ch3m
47.38
Ch3y
256.2
Ch5y
142.6
Ch6m
111.1
Change
-0.74%
Change From Open
-0.59
Close
272
Days Gap
-0.15
Depreciation Amortization
259,791,250
Dollar Volume
193,781,700
Earnings Date
2026-05-12
EBIT
INR 1.1B
EBITDA
INR 1.3B
EPS
INR 10.19
F Score
2
Fiscal Year End
March
Founded
1,984
Graham Number
160.45729
Graham Upside
-40.57
Income Tax
INR 537M
Is Primary Listing
0
Last Earnings Date
2026-02-10
Last Report Date
2025-12-31
Lynch Fair Value
INR 92.73
Lynch Upside
-65.66
Ma150
189.8
Ma150ch
42.25%
Ma20
265.3
Ma20ch
1.76%
Next Earnings Date
2026-05-12
Open
271.6
Payment Date
2026-03-12
Position In Range
14.17
Price Date
2026-05-08
Price EBITDA
INR 21.29
Ptbv Ratio
2.53
Relative Volume
0.47x
Revenue
8,681,054,000x
Tax By Revenue
6.19x
Tax Rate
31.95%
Tr6m
111.56%
Volume
717,710
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

NSE/BLISSGVS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.4%
$1.00 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+14.9%
0 consecutive years of growth
Total shareholder yield
-0.7%
Next ex-dividend date: 2026-02-18
Performance

NSE/BLISSGVS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+135.3%
S&P 500 1Y: n/a
3Y total return
+262.0%
S&P 500 3Y: n/a
5Y total return
+149.3%
S&P 500 5Y: n/a
10Y total return
+162.8%
S&P 500 10Y: n/a
Ownership

Who owns NSE/BLISSGVS?

Insider, institutional, and short-interest positioning.

Institutional ownership
+10.9%
Share of float held by funds and institutions
Insider ownership
+44.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+1.1%
Negative means the company is buying back shares.
Technical

NSE/BLISSGVS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
59.8
Neutral momentum band
Price vs 200-day MA
+47.8%
50/200-day relationship not available
Beta (5Y)
0.95
Moves roughly with the market
Sharpe ratio
1.67
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NSE/BLISSGVS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/BLISSGVS stock rating?

nse/BLISSGVS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/BLISSGVS analysis?

The full report lives at /stocks/nse/BLISSGVS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/BLISSGVS?

The latest report frames nse/BLISSGVS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/BLISSGVS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.